Skip to main content

Akero Therapeutics Inc. Common Stock (AKRO)

About The Company

AKRO Stock Market Logo

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company’s product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

IPO Year Sector Industry
2019 Health Care Biotechnology: Pharmaceutical Preparations

Akero Therapeutics Inc. (AKRO) Latest News

Company Contact & Address (AKRO)

Corporate Headquarters Phone Website
United States
+1 650 487-6488 Official AKRO Website

AKRO Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ AKRO

Jobs & Employment at Akero Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page Careers, Jobs, Employment at Akero Therapeutics Inc. (AKRO)

Related & Similar Stock Symbols

AFRIW Stock Market Price & News


Forafric Global PLC Warrants

DLR Stock Market Price & News


Digital Realty Trust Inc. Common Stock

MYMD Stock Market Price & News


MyMD Pharmaceuticals Inc. Common Stock